Comparison Overview
PPD™ Biotech Solutions

PPD™ Biotech Solutions
929 North Front Street, Wilmington, NC, 28401, US
Last Update: 06/01/2026
PPD™ Biotech Solutions has been on the leading edge of bringing value to emerging biotech and pharma companies. Our mindset is to simplify your drug development journey by combining hands-on attention and flexibility with global reach and end-to-end expertise. We can s...

AUROBINDO PHARMA LTD
Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District,, Hyderabad, 500032, IN
Last Update: 13/09/2026
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, brand...
Compliance Ranges Comparison

PPD™ Biotech Solutions







AUROBINDO PHARMA LTD






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for PPD™ Biotech Solutions in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for AUROBINDO PHARMA LTD in 2026.
Incident History - PPD™ Biotech Solutions (X = Date, Y = Severity)
PPD™ Biotech Solutions cyber incidents detection timeline including parent company and subsidiaries.
Incident History - AUROBINDO PHARMA LTD (X = Date, Y = Severity)
AUROBINDO PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

PPD™ Biotech Solutions

AUROBINDO PHARMA LTD
FAQ
Latest Global CVEs
A vulnerability was detected in mathurvishal CloudClassroom-PHP-Project up to 5dadec098bfbbf3300d60c3494db3fb95b66e7be. This impacts an unknown function of the file viewresult.php. Performing a manipulation of the argument seno results in sql injection. Remote exploitation of the attack is possible. The exploit is now public and may be used. This product follows a rolling release approach for continuous delivery, so version details for affected or updated releases are not provided. The vendor was contacted early about this disclosure but did not respond in any way.
Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)
Uncontrolled Resource Consumption (CWE-400) in Kibana can lead denial of service via Excessive Allocation (CAPEC-130)
Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)
Uncontrolled Resource Consumption (CWE-400) in Elasticsearch can lead denial of service via Excessive Allocation (CAPEC-130)